AI-generated summary
The authors studied photobiomodulation therapy in rats with nerve-injury-induced neuropathic pain, measuring pain behavior and spinal cord levels of epigenetic and pain-related factors. They report that the therapy reduced allodynia and hyperalgesia after three weeks and increased TGF-β and GAD65, while expression of NRSF, HDAC1 and DNMT3a was not inhibited.
- Who or what was studied
- Rats with chronic constriction injury (CCI) neuropathic pain model
- Limits stated in the abstract
- The abstract describes an animal model study and does not report sample size or control group details.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.